GVK locks down contract extension with FDA; PwC: Industry faces R&D talent gap;

> The FDA has extended its license of GVK Biosciences' biomarker database, which it uses in its biomarker qualification process. News

> PerkinElmer ($PKI) narrowed its losses in the fourth quarter, thanks in part to a 6% revenue jump in its human health unit. Article

> There's a talent gap in the biopharma world, according to PricewaterhouseCoopers, making it hard for companies in the industry to find hirable R&D workers. That's led to a whole host of innovative approaches, including academic partnerships and crowdsourcing. More

> CMO Lonza is suggesting cutbacks in its manufacturing division, planning to "move from a product-oriented to a market-oriented organization." Story

> CRO ClinPharm Consulting has changed its name to Kinetigen, saying the switch reflects its expanded role in the industry and evolution into a pharmacology and pharmacokinetics operation. Item

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.